CRYOPORT, INC. Additional Paid in Capital, Common Stock
CRYOPORT, INC. (CYRX) had Additional Paid in Capital, Common Stock of $1.12 billion as of 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-05-04
- 2023-03-31: Additional Paid in Capital, Common Stock $1.12B.
- 2022-12-31: Additional Paid in Capital, Common Stock $1.11B.
- 2022-09-30: Additional Paid in Capital, Common Stock $1.09B.
- 2022-06-30: Additional Paid in Capital, Common Stock $1.08B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2023-03-31 | $1.12B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.11B 10-Q · filed 2023-05-04 | |
| 2022-09-30 | $1.09B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $1.08B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.10B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.10B 10-K · filed 2023-02-28 | |
| 2021-09-30 | $846.19M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $841.54M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $837.62M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $566.45M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $300.27M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $295.42M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $290.11M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $285.61M 10-K · filed 2021-03-01 | $285.61M 10-K · filed 2020-03-10 |
| 2019-09-30 | $268.73M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $254.58M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $182.23M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $179.50M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $167.78M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $160.98M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $156.54M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $149.29M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $146.89M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $142.19M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $141.37M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $129.20M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $122.93M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $122.14M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $116.21M 10-KT · filed 2017-03-13 | |
| 2015-12-31 | $114.33M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $113.30M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $106.21M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $97.35M 10-K · filed 2016-06-28 | |
| 2014-12-31 | $92.75M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $90.59M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $87.80M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $83.57M 10-K · filed 2015-05-19 | $83.51M 10-K · filed 2014-06-25 |
| 2013-12-31 | $82.98M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $81.96M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $64.57M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $64.21M 10-K · filed 2014-06-25 | |
| 2012-12-31 | $64.01M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $63.77M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $63.70M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $63.62M 10-K · filed 2013-06-25 | |
| 2011-12-31 | $58.85M 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $58.66M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $58.21M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $58.02M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |